NCT00953446 Arterial Spin Labeling Blood Flow Magnetic Resonance Imaging for the Evaluation of Response to Therapy in Metastatic Renal Cell Carcinoma Status TERMINATED Phase NA
NCT00952107 Objective Flap Assessment During Reconstructive Surgery Status COMPLETED Phase EARLY_PHASE1
NCT00925652 Bevacizumab, Metronomic Chemotherapy (CM), Diet and Exercise After Preoperative Chemotherapy for Breast Cancer Status TERMINATED Phase PHASE2
NCT00921427 The Use of Transcranial Direct Current Stimulation (TDCS) to Enhance the Rehabilitative Effect of Vision Restoration Therapy Status COMPLETED Phase EARLY_PHASE1
NCT00916669 A Randomized Study to Evaluate the Effect of Two Different Doses of Enoxaparin Sodium in Combination With Standard Chemotherapy in Patients With Stage Small Cell Lung Cancer (SCLC) Status WITHDRAWN Phase PHASE2
NCT00916630 Treatment of Recurrent Primary or Secondary Central Nervous System (CNS) Lymphoma With ALIMTA (Pemetrexed) Status COMPLETED Phase PHASE1
NCT00916162 Drug Withdrawal in Women With Progressive Breast Cancer While on Aromatase Inhibitor Therapy Status COMPLETED Phase N/A
NCT00908960 Enoxaparin Thromboprophylaxis in Cancer Patients With Elevated Tissue Factor Bearing Microparticles Status COMPLETED Phase PHASE2
NCT00906581 Self-guided Depression Treatment on Long-duration Spaceflights: A Continuation Study Status COMPLETED Phase NA
NCT00903266 Melodic-Intonation-Therapy and Speech-Repetition-Therapy for Patients With Non-fluent Aphasia Status COMPLETED Phase PHASE3
NCT00903162 Extended Endocrine Therapy for Premenopausal Women With Breast Cancer Status COMPLETED Phase PHASE2
NCT00880334 Randomized Study of Docetaxel +/- Vandetanib in Metastatic TCC Status COMPLETED Phase PHASE2
NCT00870675 Magnetic Resonance Imaging (MRI) of Ventriculomegaly: Morphology and Outcome Status COMPLETED Phase N/A
NCT00869999 Everolimus Plus Rituximab for Relapsed/Refractory Diffuse Large B Cell Lymphoma Status COMPLETED Phase PHASE2
NCT00866723 Avastin in Patients With Epithelial Ovarian, Primary Peritoneal Serous or Fallopian Tube Cancer Status TERMINATED Phase PHASE2
NCT00859222 LBH589 and Bevacizumab in Patients With Recurrent High Grade Glioma Status COMPLETED Phase PHASE1/PHASE2